ESR1 and breast neoplasm: The data described so far imply the IGF1‐R/AKT pathway in Tel activity on FOXA1 and ERα protein levels and function and correlate FOXA1 with cell sensitivity to Tel antiproliferative effect in breast and non‐breast tumor cell lines.